Abstract
Introduction
Typical T-cell receptor (TCR)_` T cells are derived from precursors that migrate to the thymus where they undergo a series of selection and maturation processes termed positive and negative selection.
1 During positive selection, T cells with newly-arranged TCR_` complexes are tested for their ability to receive survival signals via TCR contact with self-peptides bound to major histocompatibility complex (MHC) molecules expressed on cortical epithelium: cells with low but significant reactivity for self-peptide/MHC ligands are selected for survival while low-affinity cells die in situ, thus selecting only T cells with functional TCRs. Conversely, through contact with antigen on bone marrow (BM)-derived dendritic cells (DCs), negative selection eliminates T cells with high affinity for self-peptide/MHC molecules, thus ensuring the deletion of potentially auto-reactive T cells. At the end of these selection processes, mature CD4 and CD8 T cells are generated and subsequently released into the bloodstream for export to the secondary lymphoid organs. Despite the fact that these cells are selected on self-peptide/MHC molecules in the thymus, the cells have not yet seen foreign antigens and are thus immunologically naïve.
Post-thymic naïve T cells recirculate continuously between blood and lymph through the lymphoid tissues and remain in interphase, rarely if ever dividing.
2,3 Activation of naïve T cells occurs in the secondary lymphoid organs, such as lymph nodes and spleen, upon encounter with their cognate antigen in the form of peptides bound to MHC molecules presented by mature antigen-presenting cells (APCs) that express costimulatory molecules, notably DCs. 4 Upon activation, T cells undergo vigorous clonal expansion and differentiate into effector cells which then home to the site of infection. These primed cells can directly exert their effector functions upon TCR engagement without the necessity for costimulatory signals; effector CD8 cells kill pathogen-infected cells whereas activated CD4 cells provide "help" for CD8 cell differentiation or induce B-cells to produce high-affinity antibodies.
At the end of the expansion of antigen-specific T cells, which usually occurs after the pathogen has been eliminated, the immune response undergoes a contraction phase where most antigen-specific effector T cells die via apoptosis. 5, 6 However, a minority (about 5%) of antigen-specific T cells survive to become long-lived memory cells. 7, 8 These cells are resting cells but, unlike naïve T cells, memory cells display certain surface markers (such as a high density of CD44 in mice) which distinguish these cells from naïve T cells. Notably, unmanipulated normal mice contain significant numbers of cells with high expression of CD44 (CD44 hi ), thus closely resembling memory T cells found after deliberate antigen priming.
8,9 These CD44 hi "memory-phenotype" (MP) cells account for about 10-15% of total T cells in young mice but become a majority population in old age; MP cells are thought to represent the descendents of T cells reacting to ubiquitous environmental or self-antigens. T cells, by contrast, homeostasis depends on contact with both IL-7 and IL-15, while TCR contact with self-peptide/MHC-I ligands is relatively unimportant. [13] [14] [15] Similar to their CD8 counterparts, memory CD4 cells also require signals from IL-7 and IL-15 and do not depend on contact with MHC (MHC-II) molecules. [16] [17] [18] Typical memory and MP cells are resting cells which divide intermittently through contact with IL-15, the density of CD122, the receptor for IL-15, being higher on memory cells than naïve cells.
19 It should be mentioned that about one-third of MP cells are activated cells; these cells ignore cytokines and seem to be engaged in chronic responses to unknown self-peptide/MHC ligands, both for CD4 and CD8 cells.
20,21
IL-7 and IL-15 belong to the family of common gamma chain (a c ) cytokines, which share usage of the a c receptor (also called CD132). This family also includes another cytokine that plays a central role in T-cell homeostasis, namely IL-2. This cytokine exerts complex effects on typical mature T cells and is also primarily responsible for the survival of CD4 CD25 T regulatory cells (Tregs).
22 IL-2 is a 15 kDa short-chain four _-helical bundle cytokine and is produced mainly by activated CD4 T helper cells, although activated CD8 T cells, natural killer (NK) cells, NK T cells and DCs stimulated with microbial products are also able to secrete IL-2, albeit in low amounts.
23-29 IL-2 acts in an autocrine or paracrine fashion by binding to IL-2 receptors (IL-2Rs).
30
High-affinity IL-2Rs are trimeric receptors consisting of IL-2R_ (CD25), IL-2R` (CD122) and the a c chain (Fig. 1) ; these receptors bind strongly to IL-2 with a dissociation constant (K d ) of about 10 <11 M. [31] [32] [33] Trimeric IL-2Rs are found on Tregs as well as on recently-activated normal T cells. 30, 34 In addition to trimeric IL-2Rs, IL-2 can also bind to dimeric IL-2Rs consisting of CD122 and a c , albeit with a 100-fold lower affinity (K d ¾10 <9 M). Dimeric IL-2Rs bind IL-15 in addition to IL-2 (Fig. 1) and are found at high levels on resting memory and MP CD8 cells as well as NK cells and at low but significant levels on naïve CD8 cells. Notably, CD122 and a c are responsible for mediating intracellular signaling whereas CD25 confers high-affinity binding to IL-2 but does not directly contribute to signal transduction. 31 Below, we will review the role of IL-2 in CD8
T-cell responses in vivo; the in vitro actions of IL-2 have been reviewed extensively elsewhere. [30] [31] [32] [33] In particular, we will discuss the contribution of IL-2 to the different phases of a CD8
T-cell response, starting with CD8 cell activation and expansion, followed by the contraction phase and then the memory phase. During each of these different stages, IL-2 has a decisive effect on CD8 cells. Thus, by controlling initial T-cell expansion
